Options & Mergers Analyst Glick, Pharmaceuticals Analyst Scala and Biotech Analyst Werber review the Prometheus Biosciences and Merck deal on an Analyst/Industry Webinar to be held on April 21 at 10:30. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RXDX:
- Biotech Alert: Searches spiking for these stocks today
- Prometheus downgraded to Equal Weight from Overweight at Wells Fargo
- Prometheus downgraded to Sector Perform from Outperform at RBC Capital
- Prometheus downgraded to Neutral from Outperform at Credit Suisse
- Prometheus downgraded to Neutral from Overweight at Piper Sandler
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue